Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
59.94
-1.16 (-1.90%)
At close: Nov 5, 2025, 4:00 PM EST
62.44
+2.50 (4.17%)
After-hours: Nov 5, 2025, 5:53 PM EST
Bio-Techne Revenue
Bio-Techne had revenue of $286.56M in the quarter ending September 30, 2025, a decrease of -1.00%. This brings the company's revenue in the last twelve months to $1.22B, up 3.85% year-over-year. In the fiscal year ending June 30, 2025, Bio-Techne had annual revenue of $1.22B with 5.23% growth.
Revenue (ttm)
$1.22B
Revenue Growth
+3.85%
P/S Ratio
7.87
Revenue / Employee
$392,494
Employees
3,100
Market Cap
9.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.22B | 60.58M | 5.23% |
| Jun 30, 2024 | 1.16B | 22.36M | 1.97% |
| Jun 30, 2023 | 1.14B | 31.10M | 2.81% |
| Jun 30, 2022 | 1.11B | 174.57M | 18.75% |
| Jun 30, 2021 | 931.03M | 192.34M | 26.04% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
TECH News
- 5 hours ago - Bio-Techne Corporation (TECH) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 11 hours ago - Bio-Techne misses quarterly sales estimates on weak biotech demand - Reuters
- 11 hours ago - Bio-Techne Releases First Quarter Fiscal 2026 Results - PRNewsWire
- 11 hours ago - BIO-TECHNE DECLARES DIVIDEND - PRNewsWire
- 1 day ago - AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients - PRNewsWire
- 2 days ago - ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics - PRNewsWire
- 8 days ago - Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research - PRNewsWire
- 13 days ago - ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital - PRNewsWire